Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,205
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
  • Oct 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 16,981–17,000 of 17,350 recalls

FDA Recall Terminated Historical recordClass II

Vicks NyQuil Cold & Flu, Nighttime Relief, 12 FL OZ bottle, Dist. by Proctor and Gamble, Cincinnati, OH 45040. NDC 37000-808-12

by Procter & Gamble Co

Reason
Labeling Illegible: Portions of the product labeling in the area of the dosing directions, the warnings & other information sections is obscured.
Published
December 5, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

by GlaxoSmithKline, LLC.

Reason
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Published
December 5, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Pradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT --- NDC 0597-0149-54

by Boehringer Ingelheim Roxane Inc

Reason
Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product
Published
December 5, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.

by GlaxoSmithKline, LLC.

Reason
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Published
December 5, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Advair HFA (fluticasone propionate 45 mcg and salmeterol 21 mcg) Inhalation Aerosol, 12g, 120 Metered Actuations, For Oral Inhalation with Advair HFA actuator only, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 0173-0715-20.

by GlaxoSmithKline, LLC.

Reason
Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Published
December 5, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish)

by Samantha Lynn, Inc

Reason
Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.
Published
December 5, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Orajel Kids My Way! Anticavity Fluoride (sodium fluoride) toothpaste, 0.24%, 3 oz (85 g) pump, Church & Dwight Col, Inc., Princeton, NJ 08543; UPC 3 10310 32370 7.

by Church & Dwight Inc

Reason
CGMP Deviations: Product was made with an incorrect ingredient, Laureth-9 was mistakenly substituted for PEG.
Published
November 28, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atorvastatin Calcium Tablets, 10 mg, 90-count tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257 USA; by: Ranbaxy Laboratories Ltd., New Delhi -110 019, India; NDC 63304-827-90

by Ranbaxy Inc.

Reason
Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.
Published
November 28, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dr. Reddy's Quetiapine Fumarate Tablets, 25mg, Rx Only, 500 tablets. Mfd By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325, India NDC 55111-249-05

by Dr. Reddy's Laboratories, Inc.

Reason
Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Published
November 28, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured By: Watson Laboratories, Inc., Corona, CA 92880 USA, NDC 00591-0540-05.

by Watson Laboratories Inc

Reason
Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.
Published
November 28, 2012
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

HYDROCODONE BITARTRATE and ACETAMINOPHEN TABLETS, USP, 10 mg/500 mg, 100-count bottle, Rx only, Mfg. for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-3888-21

by Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals

Reason
Superpotent (Multiple Ingredient) Drug: Confirmed customer complaints of oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Published
November 28, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Lemon Hand Sanitizing Wipes [n-alkyl dimethyl benzyl ammonium chloride (0.1%) and n-alkyl dimethyl ethyl benzyl ammonium chloride (0.1%)], labeled as a) Genuine Joe Cleaning Supplies, Lemon Scent, Anti-microbial Hand Sanitizing Wipes, 120-count premoistened wipes per bucket, 6 buckets per case, Manufactured for S.P. Richards Co., 6300 Highlands Pkwy., Smyma, GA 30082, UPC 0 35255 10477 7; b) Pro Chem Lemon Aid, Hand Sanitizing Wipes, 85-count premoistened wipes per bucket, 6 buckets per case, An exclusive product of: Pro Chem, Inc., 1475 Bluegrass Lakes Parkway, Alpharetta, GA 30004; c) Scrubs, Lemon Hand Sanitizer Wipes, 120-count premoistened wipes per bucket, 6 buckets per case, Manufactured in the U.S.A. by ITW Dymon, 805 E. Old 56 Highway, Olathe, KS 66061, UPC 7 64769 92991 9.

by ITW Dymon

Reason
CGMP Deviations: The products were manufactured with raw material which contain unknown particles believed to be water and dirt.
Published
November 21, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

All Non-Sterile Products manufactured by Ameridose LLC, Westborough, MA. A complete list of all products subject to this recall can be accessed on-line at www.ameridose.com

by Ameridose LLC

Reason
GMP deficiencies
Published
November 21, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

All Sterile Products manufactured by Ameridose LLC, Westborough, MA. A complete list of all products subject to this recall can be accessed on-line at www.ameridose.com

by Ameridose LLC

Reason
Lack of assurance of sterility
Published
November 21, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

All Non Sterile Products manufactured by NECC (New England Compounding Center), Framingham, MA. A complete list of products can be found on their website at www.neccrx.com

by New England Compounding Center

Reason
GMP Deviations
Published
November 21, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

All Sterile Products manufactured by NECC (New England Compounding Center), Framingham, MA. A complete list of products can be found on their website at www.neccrx.com

by New England Compounding Center

Reason
Lack of Assurance of Sterility
Published
November 21, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

AcneFree Acne Pore Cleanser (benzoyl peroxide 2.5% w/v), 3 oz (85 g) canister, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, UPC 7 88521 13546 2.

by Valeant Pharmaceuticals

Reason
Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.
Published
November 14, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

AcneFree Severe Maximum Strength Acne Pore Cleanser (benzoyl peroxide 5% w/v), 3 oz (85 g) canister, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, UPC 7 88521 13350 9.

by Valeant Pharmaceuticals

Reason
Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.
Published
November 14, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

AcneFree 3-in-1 Acne Night Repair Foam (retinol + salicylic acid 1.5% w/v), 3 oz (85 g) canister, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, UPC 7 88521 13548 6.

by Valeant Pharmaceuticals

Reason
Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicylic acid ingredient. Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.
Published
November 14, 2012
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

AcneFree Acne Astringent Toner Pads (salicylic acid 2% w/v); 60-count pads per jar, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA 92618, UPC 7 88521 13551 6.

by Valeant Pharmaceuticals

Reason
Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicyclic acid active ingredient.
Published
November 14, 2012
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.